Polar Asset Management Partners’s CERo Therapeutics Warrants CEROW Stock Holding History

Polar Asset Management Partners’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$8.25K	–	890
2023 Q4	$8.25K	Hold	300,000	–	–	﹤0.01%	701
2023 Q3	$21.5K	Hold	300,000	–	–	﹤0.01%	726
2023 Q2	$18.3K	Hold	300,000	–	–	﹤0.01%	810
2023 Q1	$12K	Hold	300,000	–	–	﹤0.01%	954
2022 Q4	$12.9K	Hold	300,000	–	–	﹤0.01%	1040
2022 Q3	$24K	Hold	300,000	–	–	﹤0.01%	1140
2022 Q2	$30K	Hold	300,000	–	–	﹤0.01%	1137
2022 Q1	$65K	Hold	300,000	–	–	﹤0.01%	946
2021 Q4	$126K	Buy	+300,000	New	+$138K	﹤0.01%	1096

Other funds holding CEROW

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

CSD

Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Polar Asset Management Partners's CEROW Position: Q1 2024 in Review

Polar Asset Management Partners sold out of CERo Therapeutics Warrants (CEROW) in Q1 2024, closing a stake of 300,000 shares — an estimated $8.25K sold.

Polar Asset Management Partners first reported a position in CEROW in Q4 2021 and held it in 9 quarters. The position peaked at $126K in Q4 2021. 37 funds tracked by Wall St. Rank hold CEROW as of Q1 2024.

Polar Asset Management Partners reported no remaining CERo Therapeutics Warrants position as of Q1 2024 after selling out during the quarter.
Polar Asset Management Partners sold 300,000 CERo Therapeutics Warrants shares in Q1 2024, an estimated $8.25K.
Polar Asset Management Partners first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 9 quarters.
Polar Asset Management Partners's CERo Therapeutics Warrants position peaked at $126K in Q4 2021.
37 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q1 2024.

Based on Polar Asset Management Partners's 13F filing for Q1 2024, filed 15 May 2024.